(Q39643925)

13 September 2017

Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice (English)

1 reference

13 September 2017

0 references

Guillausseau PJ

1

1 reference

13 September 2017

1 February 2003

1 reference

13 September 2017

Diabetes and Metabolism

1 reference

13 September 2017

29

1 reference

13 September 2017

1

1 reference

13 September 2017

79-81

1 reference

Use of electronic pill boxes to assess risk of poor treatment compliance: results of a large-scale trial

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970011-3

7 January 2021

Impact of dosage frequency on patient compliance.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970011-3

7 January 2021

Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970011-3

7 January 2021

The association between diabetes metabolic control and drug adherence in an indigent population

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970011-3

7 January 2021

Recall of recommendations and adherence to advice among patients with chronic medical conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970011-3

7 January 2021

The Relationship Between Health Beliefs, Adherence, and Metabolic Control of Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970011-3

7 January 2021

The impact of patient adherence on health outcomes for patients with chronic disease in the Medical Outcomes Study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970011-3

7 January 2021

10.1016/S1262-3636(07)70011-3

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

12629452